Paper34512640
Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings.
Hu M and 7 others. Front Immunol, 2021. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings. Papers, record 34512640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34512640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epitopes, T-Lymphocyte | Major topic |
| Immune Tolerance | Major topic |
| Kidney Transplantation | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Allografts | |
| Animals | |
| Bone Marrow Transplantation | |
| Clinical Trials as Topic | |
| Cytokines | |
| HLA Antigens | |
| Humans | |
| Models, Animal | |
| Treatment Outcome |
Source PubMed
References130
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18846251 | Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18846251 | PubMed |
| 2 | 22491420 | CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis. | J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22491420 | PubMed |
| 3 | 29201599 | Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance. | Curr Transplant Rep | 2017 | https://conductscience.org/library/papers/29201599 | PubMed |
| 4 | 2136906 | Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. | J Exp Med | 1990 | https://conductscience.org/library/papers/2136906 | PubMed |
| 5 | 25824574 | IL-17 deficiency attenuates allograft injury and prolongs survival in a murine model of fully MHC-mismatched renal allograft transplantation. | Am J Transplant | 2015 | https://conductscience.org/library/papers/25824574 | PubMed |
| 6 | 14726386 | Transplantation tolerance induced by intranasal administration of HY peptides. | Blood | 2004 | https://conductscience.org/library/papers/14726386 | PubMed |
| 7 | 25452562 | Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. | J Immunol | 2015 | https://conductscience.org/library/papers/25452562 | PubMed |
| 8 | 30429370 | Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. | JCI Insight | 2018 | https://conductscience.org/library/papers/30429370 | PubMed |
| 9 | 29980618 | Revisiting IL-2: Biology and therapeutic prospects. | Sci Immunol | 2018 | https://conductscience.org/library/papers/29980618 | PubMed |
| 10 | 24354870 | Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy. | Am J Transplant | 2014 | https://conductscience.org/library/papers/24354870 | PubMed |
| 11 | 29497427 | Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer. | Front Immunol | 2018 | https://conductscience.org/library/papers/29497427 | PubMed |
| 12 | 20702778 | The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. | Blood | 2010 | https://conductscience.org/library/papers/20702778 | PubMed |
| 13 | 33658995 | Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation. | Front Immunol | 2020 | https://conductscience.org/library/papers/33658995 | PubMed |
| 14 | 33125206 | A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-A Second Report. | Transplantation | 2020 | https://conductscience.org/library/papers/33125206 | PubMed |
| 15 | 12522256 | Control of regulatory T cell development by the transcription factor Foxp3. | Science | 2003 | https://conductscience.org/library/papers/12522256 | PubMed |
| 16 | 11673485 | Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. | J Immunol | 2001 | https://conductscience.org/library/papers/11673485 | PubMed |
| 17 | 18827184 | CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses. | Blood | 2009 | https://conductscience.org/library/papers/18827184 | PubMed |
| 18 | 20875655 | Cardiac allograft acceptance induced by blockade of CD40-CD40L costimulation is dependent on CD4+CD25+ regulatory T cells. | Surgery | 2011 | https://conductscience.org/library/papers/20875655 | PubMed |
| 19 | 17130784 | Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. | Transplantation | 2006 | https://conductscience.org/library/papers/17130784 | PubMed |
| 20 | 28222739 | Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression. | J Transl Med | 2017 | https://conductscience.org/library/papers/28222739 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985516 | Antigen-specific regulatory cell therapy approaches in kidney transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42985516 | PubMed |
| 42358982 | CD25+CD27+CD70- alloantigen-specific Tregs: promising stable immunotherapy for transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42358982 | PubMed |
| 41133815 | Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41133815 | PubMed |
| 40936404 | Regulatory T cell therapy in solid organ transplantation: clinical applications and laboratory monitoring strategies. | Clin Transplant Res | 2025 | https://conductscience.org/library/papers/40936404 | PubMed |
| 40558103 | Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy? | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/40558103 | PubMed |
| 39850891 | ESAT-6 protein suppresses allograft rejection by inducing CD4+Foxp3+ regulatory T cells through IκBα/cRel pathway. | Front Immunol | 2024 | https://conductscience.org/library/papers/39850891 | PubMed |
| 38516885 | Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance. | JCI Insight | 2024 | https://conductscience.org/library/papers/38516885 | PubMed |
| 38426492 | A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models. | J Clin Invest | 2024 | https://conductscience.org/library/papers/38426492 | PubMed |
| 37874660 | Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function. | JCI Insight | 2023 | https://conductscience.org/library/papers/37874660 | PubMed |
| 37629531 | Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37629531 | PubMed |
| 36675265 | Treg Therapy for the Induction of Immune Tolerance in Transplantation-Not Lost in Translation? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675265 | PubMed |
| 36599351 | Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/36599351 | PubMed |
| 36311730 | Complement-targeted therapies in kidney transplantation-insights from preclinical studies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36311730 | PubMed |
| 36009272 | Ozone Pollution, Oxidative Stress, Regulatory T Cells and Antioxidants. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36009272 | PubMed |
| 35955623 | Wasabi Component 6-(Methylsulfinyl)hexly Isothiocyanate and Derivatives Improve the Survival of Skin Allografts. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955623 | PubMed |
| 35874735 | Cellular Immune Responses in Islet Xenograft Rejection. | Front Immunol | 2022 | https://conductscience.org/library/papers/35874735 | PubMed |
| 35720402 | Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720402 | PubMed |
| 35146940 | Light-Controllable Binary Switch Activation of CAR T Cells. | ChemMedChem | 2022 | https://conductscience.org/library/papers/35146940 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34512640
GET https://conductscience.org/api/papers/v1/34512640/references?page=2